Working… Menu

Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04274803
Recruitment Status : Withdrawn (no patient enrolled)
First Posted : February 18, 2020
Last Update Posted : June 14, 2021
Information provided by (Responsible Party):
Ayman S Dawood, MD, Tanta University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : May 31, 2021
Estimated Study Completion Date : May 31, 2021